Serviços clínicos farmacêuticos na farmácia hospitalar e suas consequências para qualidade da assistência ao paciente: uma revisão integrativa.

Abstract

The pharmacist working in the hospital pharmacy must contribute to the care and safety of patients. With this, the implementation of the hospital clinical pharmacy seeks to offer pharmaceutical services, which together with the multiprofessional team, generate better health outcomes for patients. Thus, this study aimed to carry out an integrative review on hospital pharmaceutical clinical services and their results in the quality of patient care. Data collection was carried out in the PubMed and Regional Portal of the Virtual Health Library (BVS) databases during the period from July 20 to 4, 2022, to identify potential studies on the subject between the years 2013 to 2022. At the end of the selection of articles, 31 studies remained that were included in this review. According to the data extracted from the studies, the oncology sector was the one that most obtained results from these pharmaceutical services, in which the analysis of prescription and medication reconciliation are the most used. As the main consequence of the availability of clinical pharmaceutical services, most studies reported a reduction in drug-related problems (DRP), in addition to a reduction in costs, after the intervention of these pharmaceutical services. From this, it is concluded that hospital pharmaceutical services contribute to the detection and resolution of DRPs, ensuring greater safety and quality in patient care. In addition to helping to prevent errors, adherence to pharmacotherapy, increasing quality of life by ensuring that patient care is effective. As a consequence, a decrease in hospital costs is obtained due to the positive results of pharmaceutical interventions.